Fundz
Free weekly newsletter

Get the free weekly contract digest

The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New new contracts, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Contract Trends

See who's moving and how much in your market

No credit card required Weekly contract digest

Antiverse partners with i&i Biotech Fund I and Kadmos Capital to secure £3.5 M ($4.6 M) for advancing generative AI antibody design platform

Oct 16, 2024•over 1 year ago

Contract Type

partnership

CardiffBiotechnologyHealth CareTherapeutics

Description

Antiverse has announced a partnership with i&i Biotech Fund I and Kadmos Capital to secure £3.5 M ($4.6 M) in seed funding. The investment will be used to expand the company’s laboratory and machine learning teams, as well as to improve the predictive accuracy of the antibody design platform. Additionally, Antiverse will use the funding to open new facilities in Boston, MA, and Prague, Czech Republic.

Company Information

Company

Antiverse

Location

Cardiff, Wales, United Kingdom

About

Antiverse is a techbio company focused on designing antibodies for challenging targets using a machine-learning-centered approach. Their platform enhances predictive accuracy by utilizing target-specific libraries generated from structural and sequence data. Antiverse aims to accelerate the antibody discovery process, making difficult targets druggable and bringing vital therapies to patients. The company is actively expanding its team and facilities to support its growth and research initiatives.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Antiverse's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.